HK1039332A1 - Piperidinemethanol and their use as prodrugs of the 5ht2a receptor antagonist mdl 110,907. - Google Patents

Piperidinemethanol and their use as prodrugs of the 5ht2a receptor antagonist mdl 110,907.

Info

Publication number
HK1039332A1
HK1039332A1 HK02100869A HK02100869A HK1039332A1 HK 1039332 A1 HK1039332 A1 HK 1039332A1 HK 02100869 A HK02100869 A HK 02100869A HK 02100869 A HK02100869 A HK 02100869A HK 1039332 A1 HK1039332 A1 HK 1039332A1
Authority
HK
Hong Kong
Prior art keywords
piperidinemethanol
prodrugs
receptor antagonist
5ht2a receptor
antagonist mdl
Prior art date
Application number
HK02100869A
Inventor
A A Carr
Van L E Hijfte
Raymond W Kosley Jr
Original Assignee
Aventis Pharma Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma Inc filed Critical Aventis Pharma Inc
Publication of HK1039332A1 publication Critical patent/HK1039332A1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D211/20—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms
    • C07D211/22—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms by oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Psychiatry (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Diabetes (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Addiction (AREA)
  • Pain & Pain Management (AREA)
  • Epidemiology (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
HK02100869A 1998-10-14 2002-02-05 Piperidinemethanol and their use as prodrugs of the 5ht2a receptor antagonist mdl 110,907. HK1039332A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US1998/021608 WO2000021930A1 (en) 1998-10-14 1998-10-14 Esters of (+)-alpha-( 2,3- dimethoxyphenyl) -1-[2-(4- fluorophenyl) ethyl]-4- piperidinemethanol and their use as prodrugs of the 5ht2a receptor antagonist mdl 110,907

Publications (1)

Publication Number Publication Date
HK1039332A1 true HK1039332A1 (en) 2002-04-19

Family

ID=22268079

Family Applications (1)

Application Number Title Priority Date Filing Date
HK02100869A HK1039332A1 (en) 1998-10-14 2002-02-05 Piperidinemethanol and their use as prodrugs of the 5ht2a receptor antagonist mdl 110,907.

Country Status (21)

Country Link
EP (1) EP1121345A1 (en)
JP (1) JP2002527422A (en)
KR (1) KR100515429B1 (en)
CN (1) CN1160333C (en)
AU (1) AU1083099A (en)
BR (1) BR9816049A (en)
CA (1) CA2347469C (en)
CZ (1) CZ20011331A3 (en)
EA (1) EA003667B1 (en)
EE (1) EE200100219A (en)
HK (1) HK1039332A1 (en)
HR (1) HRP20010278A2 (en)
HU (1) HUP0200517A3 (en)
IL (2) IL142479A0 (en)
NO (1) NO320417B1 (en)
NZ (1) NZ510631A (en)
PL (1) PL193306B1 (en)
SK (1) SK5082001A3 (en)
TR (1) TR200101047T2 (en)
UA (1) UA57859C2 (en)
WO (1) WO2000021930A1 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020099076A1 (en) * 2000-05-25 2002-07-25 Richard Scheyer D. Use of (+)-a-(2,3-dimethoxyphenyl)-1-[2-(4-fluorophenyl) ethyl]-4-piperidinemethanol or its prodrug in the treatment of symptoms of dementia and dopamine induced psychosis
CN102241667B (en) * 2010-05-14 2013-10-23 中国人民解放军军事医学科学院毒物药物研究所 1-[(4-hydroxypiperidine-4-yl) methyl] pyridine-2(1H)-one derivatives, preparation method and use thereof
CN106892897A (en) * 2015-12-21 2017-06-27 上海科胜药物研发有限公司 A kind of hydroxyl piperazine pyrrone free alkali novel crystal forms and preparation method thereof
CN106928187A (en) * 2015-12-31 2017-07-07 上海奥博生物医药技术有限公司 A kind of hydrochloric acid hydroxyl piperazine pyrrone novel crystal forms and preparation method thereof

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU652759B2 (en) * 1990-06-01 1994-09-08 Aventisub Ii Inc. (+)-alpha-(2,3-dimethoxyphenyl)-1-(2-(4-fluorophenyl)ethyl)- 4-piperidinemethanol

Also Published As

Publication number Publication date
KR100515429B1 (en) 2005-09-20
HRP20010278A2 (en) 2002-06-30
WO2000021930A1 (en) 2000-04-20
SK5082001A3 (en) 2001-11-06
CA2347469C (en) 2006-02-28
AU1083099A (en) 2000-05-01
HUP0200517A3 (en) 2002-12-28
NO320417B1 (en) 2005-12-05
TR200101047T2 (en) 2001-08-21
NO20011805D0 (en) 2001-04-09
PL347318A1 (en) 2002-03-25
BR9816049A (en) 2001-07-03
IL142479A (en) 2006-06-11
EE200100219A (en) 2002-08-15
NO20011805L (en) 2001-06-08
PL193306B1 (en) 2007-01-31
CN1160333C (en) 2004-08-04
CZ20011331A3 (en) 2001-08-15
HUP0200517A2 (en) 2002-06-29
KR20010106517A (en) 2001-11-29
EA200100361A1 (en) 2001-10-22
CA2347469A1 (en) 2000-04-20
NZ510631A (en) 2003-07-25
EA003667B1 (en) 2003-08-28
EP1121345A1 (en) 2001-08-08
UA57859C2 (en) 2003-07-15
JP2002527422A (en) 2002-08-27
CN1314887A (en) 2001-09-26
IL142479A0 (en) 2002-03-10

Similar Documents

Publication Publication Date Title
HU9503402D0 (en) Neurokinin receptor antagonists
GC0000108A (en) 4-Amino substituted-2-substituted-1,2,3,4-tetrahy droquinolines.
IL150033A0 (en) Selective neurokinin antagonists
HUP0200312A3 (en) Substituted 2-phenylbenzimidazoles, pharmaceutical compositions containing them, the production thereof and their use
PL353969A1 (en) Substituted 2-thio-3,5-dicyano-4-aryl-6-aminopyridines and the use thereof as adenosine receptor ligands
HUP0102470A3 (en) 1,3-azole derivatives as retinoid-associated receptor regulators and their use
HUP9904622A3 (en) 1,4-di-sustituted piperidines as muscarinic antagonists
IL142045A0 (en) Naphthalenecarboxamides as tachykinin receptor antagonists
AU1667500A (en) N-(2-phenyl-4-piperidinybutyl)-5,6,7,8-tetrahydro-1-naphthal necarboxamides and their use as neurokinin 1 (nk1) and/or neurokinin 2 (nk2) receptor antagonists
ZA200104187B (en) 1-Amino-alkylcyclohexanes as 5-HT3 and neuronal nicotinic receptor antagonists.
IL134572A0 (en) Substituted 1,2,3,4,5,6-hexahydro-2,6- methano-3-benzazocine-10-oles, methods for the production and use thereof as medicaments
IL144741A0 (en) 1-aryl-1,3,5-triazine-4-thione-2,6-diones, production thereof and use thereof as herbicides
PL338453A1 (en) 2-acylaminopropanoamines as antagonists of the tachykinin receptor
EP1073419A4 (en) Sustained-release composition including amorphous polymer
HK1039332A1 (en) Piperidinemethanol and their use as prodrugs of the 5ht2a receptor antagonist mdl 110,907.
GB9820014D0 (en) Receptor antagonists and uses thereof
GB9705861D0 (en) Trypthophan ureas as neurokinin antagonists
HUP9903653A3 (en) Substituted arylalkylamines as neurokinin antagonists
PL338456A1 (en) 2-acylaminopropanoamines as antagonists of the tachykinin receptor
MXPA02005731A (en) Interleukin 1 receptor antagonist like molecules and uses thereof.
HUP0100540A3 (en) Substituted oximes as neurokinin antagonists
GB9819420D0 (en) Novel receptor
IL136119A0 (en) Flame resistant polyolefin compositions and methods for the preparation thereof
IL149607A0 (en) Substituted 1,2,3,4,5,6-hexahydro-2,6-methano-3 benzazocines and the use thereof as medicaments
MXPA02005775A (en) Interleukin 1 receptor antagonist related molecules and uses thereof.

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20091014